Three-quarters of European companies have set emission-reduction goals, but details of how they intend to achieve them are lacking, while only one in ten is on track to hit net-zero targets, finds recent research. Pressure is growing on corporates – and regulators – to take more action.
With its landmark deal, a South African private healthcare group has saved itself at least 21 basis points in the cost of funding and set a quartet of key performance indicators – three with environmental targets and one focused on patient satisfaction.
Retirement village operator Summerset has inked a landmark sustainability-linked loan related to reductions in carbon emissions and construction waste and, less typically, the development of dementia care. Its domestic peers are also expected to take the green finance path.
The US drugs giant will use proceeds from its second sustainability bond issue to tackle the pandemic, including in emerging markets. ESG head Chris Gray seeks to dispel scepticism by explaining the deal's rationale, while treasurer Brian McMahon discusses the $1bn bond’s pricing.
The A$150bn pension fund is using its financial heft to address modern slavery and has developed a risk-assessment tool to support its reporting requirements. But while some asset managers have shown overwhelming support, others are still burying their heads in the sand.
Medical device maker Nipro has become a rare Japanese issuer of a sustainability-linked loan, and the first from the healthcare sector. Disclosed details are limited, but it aims to use the proceeds to help address Covid-19 issues and generally improve public health both domestically and overseas.
The year to date has seen record-breaking support for shareholder resolutions, with asset managers such as BlackRock and Vanguard stepping up their stewardship. However, a lack of data on the real-world impact means the jury is still out on their efficacy.
Companies across the globe, from banks to beauty product purveyors, risk losing the best staff if they fail to take account of a new generation of executives' greater ethical awareness and willingness to act on it.
The region's healthcare providers have been slow to embrace sustainable funding because it is tricky to set measurable key performance indicators in the sector – but that is changing.
With many classified funds containing questionable stocks, the EU’s Sustainable Finance Disclosure Regulation is upsetting asset managers who feel their focus on impact is being undermined as a result.
Privately owned companies are integrating ESG disclosure into their financing agreements at the fastest rate on record as new sustainability regulations and shifting investor demand push one of the most secret market segments to come out.
The development of new ways to apply sustainable capital is truly exciting, but investors must pay close attention to how new fund offerings are created and the ESG data on which they are predicated.